Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | MLKL | Q8NB16 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3859898 | 1.00 | ACP3 (0.55) | ACP3EPHX1MLKLACHETAAR1 | |
| SCHEMBL30502803 | 1.00 | ACP3 (0.55) | ACP3EPHX1MLKLACHETAAR1 | |
| SCHEMBL822105 | 0.93 | ACHE (0.52) | ACP3EPHX1MLKLACHETAAR1 | |
| SCHEMBL822299 | 0.89 | ACP3 (0.44) | ACP3EPHX1MLKLACHELMNA | |
| SCHEMBL12792239 | 0.87 | ACHE (0.52) | ACP3EPHX1MLKLACHETAAR1 | |
| SCHEMBL12415923 | 0.86 | TAAR1 (0.46) | ACP3EPHX1MLKLTAAR1OPRM1 | |
| SCHEMBL11409330 | 0.86 | ACHE (0.48) | ACP3EPHX1MLKLACHE | |
| SCHEMBL13027665 | 0.84 | TACR1 (0.46) | ACP3MLKLSMN1; SMN2SLC6A2SLC6A4 | |
| SCHEMBL23428902 | 0.84 | CYP3A4 (0.42) | ACP3ACHESMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL8736883 | 0.84 | CYP19A1 (0.46) | ACP3ACHESMN1; SMN2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | UDC IRELAND LIMITED (IE) | 2021-11-09 | — | — | US | disclosed |
| EP-3828173-A1 | SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BioCryst Pharmaceuticals, Inc. (US) | 2021-06-02 | — | — | EP | disclosed |
| WO-2020155595-A1 | AEROBIC OXIDATION SYSTEM CONTAINING SULFINIC ACID, SULFONIC ACID OR DERIVATIVES THEREOF AND PHOTOCATALYTIC OXIDATION METHOD THEREFOR | 清华大学 | 2020-08-06 | — | — | WO | disclosed |
| CN-109053754-B | Synthetic method for constructing polysubstituted chroman compound based on biomass source 2, 5-dimethylfuran dearomatization cycloaddition strategy | 青岛农业大学 | 2020-04-07 | — | — | CN | disclosed |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | TOKYO ELECTRON LIMITED (JP) | 2018-07-17 | — | — | US | disclosed |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | TOKYO ELECTRON LIMITED (JP) | 2018-07-17 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-9971247-B2 | Pattern-forming method | OSAKA UNIVERSITY (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9971247-B2 | Pattern-forming method | OSAKA UNIVERSITY (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20080045757-A1 | Chiral Tertiary Aminoalkylnaphthols | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2008-02-21 | — | — | US | disclosed |
| US-7304057-B2 | Substituted 6-membered N-heterocyclic compounds and method for their use as neurological regulator | Institute of Pharmacology and Toxicology Accademy of Military Medical Sciences P.L.A. China (CN) | 2007-12-04 | — | — | US | disclosed |
| EP-0983222-B1 | PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS | NYMOX CORP (CA) | 2007-11-28 | — | — | EP | disclosed |
| US-7291753-B2 | Transfer hydrogenation processes and catalysts | ABDUR-RASHID KAMALUDDIN | 2007-11-06 | — | — | US | disclosed |
| US-20070213361-A1 | Preventive and/or therapeutic agent for neutrophilic inflammatory diseases | KYOWA KIRIN CO., LTD. (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070213361-A1 | Preventive and/or therapeutic agent for neutrophilic inflammatory diseases | KYOWA KIRIN CO., LTD. (JP) | 2007-09-13 | — | — | US | disclosed |
| CN-1930116-A | Chiral tertiary aminoalkylnaphthols | UNIV HONG KONG POLYTECHNIC (HK) | 2007-03-14 | — | — | CN | disclosed |
| US-20050130958-A1 | Substituted 6−membered n−heterocyclic compounds and their uses as neurological regulator | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2005-06-16 | — | — | US | disclosed |
| CN-1173960-C | Substituted hexa azacylo compounds and their use as neuroregulator | �й������ž�����ҽѧ��ѧԺ����ҩ | 2004-11-03 | — | — | CN | disclosed |
| CN-1422852-A | Substituted hexa azacylo compounds and their use as neuroregulator | TOXICANT AND MEDICINE INST MIL (CN) | 2003-06-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | ASIC1, ASIC3, CLTA | ACP3 1387/4885EPHX1 2407/4885MLKL 778/4885 |
| US-20080045757-A1 | Chiral Tertiary Aminoalkylnaphthols | ALDH7A1, ADH5, ALDH1A1 | ACP3 2390/4885EPHX1 74/4885MLKL 4852/4885 |
| US-11171293-B2 | Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element | L1CAM, OR10J3, INTS9 | ACP3 4831/4885EPHX1 188/4885MLKL 2886/4885 |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | SLC11A2, XRCC5, RAD54L | ACP3 1408/4885EPHX1 3210/4885MLKL 1306/4885 |
| US-20070213361-A1 | Preventive and/or therapeutic agent for neutrophilic inflammatory diseases | MPO, MSR1, NR4A3 | ACP3 1595/4885EPHX1 827/4885MLKL 3203/4885 |
| US-20050130958-A1 | Substituted 6−membered n−heterocyclic compounds and their uses as neurological regulator | BDNF, NGF, NTRK2 | ACP3 1126/4885EPHX1 2936/4885MLKL 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.